Sophoricoside from sophora japonica L. is efficacious as monotherapy or in combination with lenvatinib in hepatocellular carcinoma via targeting EGFR
Wenqing Xi, Jinzhu Wang, Changhong Luo, Ping Zhan, Qinliang Fang, Qin Yao, Fuqiang Wang, Chengrong Xie, Zhenyu Yin · 2025
Read Sophoricoside from sophora japonica L. is efficacious as monotherapy or in combination with lenvatinib in hepatocellular carcinoma via targeting EGFR by Wenqing Xi, Jinzhu Wang, Changhong Luo, Ping Zhan, Qinliang Fang, Qin Yao, Fuqiang Wang, Chengrong Xie, Zhenyu Yin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12834961.txt.
Description
Wenqing Xi and co-authors test a plant compound from the pagoda tree against liver cancer, alone and with a standard drug, in a research paper from 2025. The compound, sophoricoside, had shown anti-cancer hints in other settings but lacked a full study in this cancer. The team probed cell cultures and tumors in animals.
The compound slowed cancer cell growth and survival and froze their division cycle. Paired with lenvatinib, the two hit tumors harder than either alone, in dishes and in animals. The compound binds a growth receptor and triggers its breakdown, muting two signal paths the drug also targets. The pairing may sensitize stubborn tumors.
Catalog record
| CREATOR | Wenqing Xi, Jinzhu Wang, Changhong Luo, Ping Zhan, Qinliang Fang, Qin Yao, Fuqiang Wang, Chengrong Xie, Zhenyu Yin |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |